zenodoopen
Figure 1 from: Dadanbekova D, Zhakipbekov K, Kodasbayev A, Datkhayev U, Petrova G, Tachkov K (2024) Cost-effectiveness of cardiomyopathy ambulatory care with sacubitril/valsartan vs standard therapy after COVID-19 in Kazakhstan. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e115952
Figure 1 Deterministic cost-effectiveness analysis.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 0
- Access
- 16
- Reuse readiness
- 0
- Engagement
- 0